by Ian Lipman | Feb 23, 2023 | News
Client News OKYO Pharma Limited: Appointment to Scientific Advisory Board Home / Client News / OKYO Pharma Limited: Appointment to Scientific Advisory Board London and New York, NY, February 23, 2023 OKYO Pharma Limited (LSE: OKYO, NASDAQ: OKYO), an...
by Ian Lipman | Feb 22, 2023 | News
Client News Upland Resources Limited: Result of Oversubscribed Fundraise Home / Client News / Upland Resources Limited: Result of Oversubscribed Fundraise Upland Resources Limited (LSE: UPL) is pleased to announce that following the announcement on 20 February 2023 in...
by Ian Lipman | Feb 21, 2023 | News
Client News Upland Resources Limited: Subscription by Cornerstone Investors Home / Client News / Upland Resources Limited: Subscription by Cornerstone Investors The Company is pleased to announce that it has obtained conditional commitments to subscribe for...
by Ian Lipman | Feb 21, 2023 | News
Client News Roquefort Therapeutics plc: Randox Licence and Royalty Agreement Home / Client News / Roquefort Therapeutics plc: Randox Licence and Royalty Agreement Roquefort Therapeutics (LSE:ROQ, OTCQB:ROQAF), the Main Market listed biotech company focused...
by Ian Lipman | Feb 21, 2023 | News
Client News Roquefort Therapeutics plc: Investor Presentation Home / Client News / Roquefort Therapeutics plc: Investor Presentation Roquefort Therapeutics (LSE:ROQ, OTCQB:ROQAF), the Main Market listed biotech company focused on developing first in class medicines in...
Recent Comments